Laurion Capital Management’s Bicycle Therapeutics BCYC Stock Holding History

Laurion Capital Management’s Portfolio BCYC Stock Details BCYC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-31,410	Closed	-$1.91M	–	539
2021 Q4	$1.91M	Sell	31,410 -3,734	-11%	-$206K	0.02%	282
2021 Q3	$1.46M	Sell	35,144 -14,648	-29%	-$512K	0.01%	477
2021 Q2	$1.51M	Sell	49,792 -8,100	-14%	-$245K	0.01%	394
2021 Q1	$1.73M	Hold	57,892	–	–	0.01%	440
2020 Q4	$1.04M	Hold	57,892	–	–	0.01%	408
2020 Q3	$1.1M	Hold	57,892	–	–	0.01%	397
2020 Q2	$897K	Hold	57,892	–	–	0.01%	489
2020 Q1	$868K	Sell	57,892 -16,398	-22%	-$209K	0.01%	516
2019 Q4	$701K	Sell	74,290 -16,344	-18%	-$148K	0.01%	633
2019 Q3	$1.03M	Sell	90,634 -9,366	-9%	-$80.4K	0.01%	635
2019 Q2	$1.01M	Buy	+100,000	New	+$1.2M	0.01%	563

Other funds holding BCYC

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

TCM

Tybourne Capital Management Hong Kong $30.9M AUM 20.1% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

SHI

SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Laurion Capital Management's BCYC Position: Q1 2022 in Review

Laurion Capital Management sold out of Bicycle Therapeutics (BCYC) in Q1 2022, closing a stake of 31,410 shares — an estimated $1.91M sold.

Laurion Capital Management first reported a position in BCYC in Q2 2019 and held it in 11 quarters. The position peaked at $1.91M in Q4 2021. 105 funds tracked by Wall St. Rank hold BCYC as of Q1 2022.

Laurion Capital Management reported no remaining Bicycle Therapeutics position as of Q1 2022 after selling out during the quarter.
Laurion Capital Management sold 31,410 Bicycle Therapeutics shares in Q1 2022, an estimated $1.91M.
Laurion Capital Management first reported a position in Bicycle Therapeutics in Q2 2019 and held it in 11 quarters.
Laurion Capital Management's Bicycle Therapeutics position peaked at $1.91M in Q4 2021.
105 funds tracked by Wall St. Rank held Bicycle Therapeutics as of Q1 2022.

Based on Laurion Capital Management's 13F filing for Q1 2022, filed 16 May 2022.